Studies in clinical shock and hypotension. VII. Renal hemodynamics before and during treatment.
D000109:Acetylcholine / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000804:Angiotensin II / Q000627:therapeutic use; D001783:Blood Flow Velocity; D001806:Blood Urea Nitrogen; D002302:Cardiac Output; D003911:Dextrans; D004298:Dopamine / Q000627:therapeutic use; D004395:Dye Dilution Technique; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D007022:Hypotension / Q000188:drug therapy / Q000503:physiopathology*; D007545:Isoproterenol / Q000627:therapeutic use; D007668:Kidney / Q000098:blood supply* / Q000503:physiopathology; D008297:Male; D008680:Metaraminol / Q000627:therapeutic use; D008875:Middle Aged; D009638:Norepinephrine / Q000627:therapeutic use; D010952:Plasma Substitutes; D012039:Regional Blood Flow; D012769:Shock / Q000188:drug therapy / Q000503:physiopathology*; D014655:Vascular Resistance; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D003911:Dextrans; D010952:Plasma Substitutes; D014662:Vasoconstrictor Agents; D000804:Angiotensin II; D006830:Hydralazine; D008680:Metaraminol; D007545:Isoproterenol; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine